Featured Research

from universities, journals, and other organizations

Potential Obesity Treatment: Hormone Causes Body To Metabolize Stored Fat

Date:
May 13, 2004
Source:
University Of Denver
Summary:
In 1999, Drs. Miles Brennan and Ute Hochgeschewender announced their finding that melanocyte-stimulating hormone (MSH) regulates the balance of fat storage and metabolism. In April, they received a patent on the use of MSH analogs -- chemicals that mimic MSH -- as potential treatments for obesity.

DENVER -- In 1999, Drs. Miles Brennan and Ute Hochgeschewender announced their finding that melanocyte-stimulating hormone (MSH) regulates the balance of fat storage and metabolism. In April, they received a patent on the use of MSH analogs -- chemicals that mimic MSH -- as potential treatments for obesity (U.S. Patent #6,716,810).

Related Articles


Brennan is an associate research professor at the Eleanor Roosevelt Institute at the University of Denver (ERI) and Hochgeschwender is an associate member of the Oklahoma Medical Research Foundation. Their research also suggests that MSH integrates fat and glucose metabolism in the periphery, or body. The scientists began by engineering mice missing the pro-opio melanocortin (POMC) gene. The mice, which had no MSH in their bloodstream, became obese because they stored all the fat they ate without metabolizing any of it.

"We were then able to reduce their weight by adding MSH back into the peripheral circulation," says Brennan. "There are MSH receptors in essentially all peripheral tissues, and we know that mice treated with MSH experience an increase in the level of free fatty acids in the bloodstream. What we think happens is that MSH causes the adipocytes, or fat cells, to release free fatty acids, while other cells are stimulated to remove them from the bloodstream and burn them. Essentially it's a way to mobilize your stored fat for current needs."

The animals experienced no apparent ill effects with the weight loss. "The MSH has the highest activity when you have the highest level of excess weight," Brennan explains. "As the animal approaches normal weight, the effect plateaus out -- this is not going to be the anorexic's drug of choice, because when there's no more stored fat, you can't change the balance. We think it's got significant potential for obesity therapies."

MSH research pioneer Victor Hruby, agrees. "It's clear that the POMC gene and its products are involved in additional ways that Miles and his colleagues have discovered, such as feeding behavior and energy homeostasis. It continues to be an evolving, exciting story that has many implications for human health. I think they are on to something worth pursuing."

The Regents Professor in the University of Arizona Department of Chemistry, Hruby also is a professor of neuroscience, biochemistry and molecular biophysics at the university and the Arizona Research Laboratory. He and his collaborators began studying MSH in the 1970s, and have developed several hundred derivatives of the hormone over the past 35 years.

"I tell my students we're living in a revolutionary time," he says. "Who knows what we'll discover tomorrow, because it's clear there are lots of unknowns. It gets more exciting all the time, and I feel almost like I'm starting over again."

The next step is licensing the discovery and working with a pharmaceutical company to develop and test clinical therapies. Previously, Brennan and Hochgeschwender, who have collaborated since 1986, have patented mice with a range of genetic modifications to the POMC gene (U.S. Patent # 6,603,058), and a method of reducing insulin resistance (U.S. Patent #6,689,938) that could lead to potential treatments for diabetes accompanying obesity.

Denver's Eleanor Roosevelt Institute (ERI) was founded in 1961 as a private, independent research center. ERI merged with the University of Denver in 2003. The Institute is staffed by leading scientists from around the world who study Down syndrome, Lou Gehrig's disease, cancer, obesity, type II diabetes and other diseases and conditions. It is the mission of the Institute's scientists to seek an in-depth understanding of the process of life and through this understanding, work towards unlocking the mysteries of human health and disease.


Story Source:

The above story is based on materials provided by University Of Denver. Note: Materials may be edited for content and length.


Cite This Page:

University Of Denver. "Potential Obesity Treatment: Hormone Causes Body To Metabolize Stored Fat." ScienceDaily. ScienceDaily, 13 May 2004. <www.sciencedaily.com/releases/2004/05/040512041502.htm>.
University Of Denver. (2004, May 13). Potential Obesity Treatment: Hormone Causes Body To Metabolize Stored Fat. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2004/05/040512041502.htm
University Of Denver. "Potential Obesity Treatment: Hormone Causes Body To Metabolize Stored Fat." ScienceDaily. www.sciencedaily.com/releases/2004/05/040512041502.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins